Here are seven important trends:
1. The global orthobiologics market is projected to reach a $7.9 billion value by 2019.
2. It was valued at $5.7 billion in 2014.
3. It is estimated to grow at a compound annual growth rate of 6.7 percent from 2014 to 2019.
4. The orthobiologics market has seen rapid growth since 2012, due to increased research and development activities and a rising demand for orthobiologics products.
5. North America contributes the largest market share.
6. But, Asia is the fastest growing region in the global orthobiologics market.
7. Key players in the market include Biomet, Medtronic, Integra Life Sciences, Stryker, Zimmer, DePuy Synthes and Tornier.
More articles on devices:
10 key notes on DJO Global’s Q1 net sales — Net sales down 0.9%
OMNI Orthopaedics gets $6M financing: 5 things to know
Top 3 cities for pharmaceutical payments to physicians
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
